𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aflatoxin B1 metabolism by 3-methylcholanthrene-induced hamster hepatic cytochrome P-450s

✍ Scribed by Lai, T. S. ;Chiang, J. Y. L.


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
688 KB
Volume
5
Category
Article
ISSN
0887-2082

No coin nor oath required. For personal study only.

✦ Synopsis


We have studied the activation of aflatoxin B, by hamster liver microsomes and purified hamster cytochrome P-450 isozymes using a umu mutagen test. The hamster liver microsomes or S-9 fractions were much more active than rat liver microsomes or s-9 fractions in the activation of umu gene expression by aflatoxin B, metabolites. 3-Methylcholanthrene treatment increased aflatoxin B, activation by hamster liver microsomes. Two major 3methylcholanthrene-inducible cytochrome P-450 isozymes, P-450 MC1 (IIA) and P-450 MC4 (IA2), were purified from 3-methylcholanthrene-treated hamster liver microsomes, and the metabolism of aflatoxin B, by these two cytochromes was studied.

In the reconstituted enzyme system, both P-450 MCl and P-450 MC4 were highly active in the activation of aflatoxin B,, and antibodies against these P-450s specifically inhibited these activities. Antibody against P-450 MC1 inhibited the activation of aflatoxin B, by 20% in the presence of 3-methylcholanthrene-treated hamster liver microsomes. In contrast, antibody against P-450 MC4 stimulated the activity by 175%. These results indicated that hamster P-450 MC1 might convert aflatoxin 8, to more toxic metabolite@), whereas P-450 MC4 might convert aflatoxin B, to less toxic metabolite(s), than aflatoxin B, in liver microsomes. The metabolite(s) produced by both hamster cytochrome P-450 MC1 and MC4 were genotoxic in the umu mutagen test.


πŸ“œ SIMILAR VOLUMES


Induction of specific cytochrome P450s i
✍ Gordon M. Kirby; Isabelle Chemin; Ruggero Montesano; Francis V. Chisari; Matti A πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 772 KB

## Abstract The relative roles of hepatitis B virus (HBV) and aflatoxn and their possible mechanism of interaction in the etiopathogenesis of hepatocellular carcinoma (HCC) are not understood. One hypothesis is that viral infection and associated liver injury alter expression of carcinogen‐metaboli

Activation of the hepatocarcinogen aflat
✍ Herbert L. Bonkovsky πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 408 KB πŸ‘ 1 views

Twelve forms of human hepatic cytochrome P-450 were expressed in hepatoma cells by means of recombinant vaccinia viruses. The expressed P-450's were analyzed for their abilities to activate the potent hepatocarcinogens aflatoxin B1 to metabolites having mutagenic or DNA-binding properties. Five form

Kinds of mutations induced by aflatoxin
✍ Yvon Trottier; William I. Waithe; Alan Anderson πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 820 KB

## Abstract Transient expression of rat liver cytochrome P450IA2 cDNA was combined with the use of a shuttle vector as a mutational target to determine the frequency and types of mutation caused by the conversion of aflatoxin B, into genotoxic metabolites within human cells. Ad293 cells were first

Hepatic cytochrome P450 2B induction by
✍ Nims, Raymond W. ;Lubet, Ronald A. ;Diwan, Bhalchandra A. ;Mellini, Donna W. ;Ut πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 930 KB

The abilities of structural congeners of phenobarbital to induce immunoreactive hepatic cytochrome P450 2B (CYP2B) protein and associated catalytic activity (benzyloxyresorufin 0-dealkylation) in the male B6C3F1 mouse were examined. Interspecies differences in inducing ability were examined through

Molecular cloning and functional heterol
✍ Hubert H. Pauli; Toni M. Kutchan πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 434 KB

## Summary Alkaloids derived from the tetrahydrobenzylisoquinoline alkaloid (__S__)‐__N__‐methylcoclaurine represent a vast and varied structural array of physiologically active molecules. These compounds range from the dimeric bisbenzylisoquinolines, such as the muscle relaxant (+)‐tubocurarine, t